chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2 dose shot  vaccine administered.  The site of injection is swollen and red.  I had body chills and pain on the arm  plus fatigue and didn?t  feel  well  over all .  Today I don?t have chills but still pain on site and is still swollen plus fatigued on today  second  day.
No additional AE's; vaccine that underwent a temperature excursion was administered to a patient; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. There was no information about the patient's pertinent medical history, concomitant therapies or drug reactions and allergies provided.  On 27-OCT-2021, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) prefilled syringe injection, lot # T026324, expiration date 22-FEB-2023, (exact dose, injection site and route of administration were not reported) to prevent human papilloma virus infection, that underwent temperature excursion.  No additional adverse events were reported.
injection site...it doubled the size and swollen and hot; swelling...at injection site; rash at injection site; itchiness...at injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Mar-2021 and was forwarded to Moderna on 11-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (injection site...it doubled the size and swollen and hot), VACCINATION SITE SWELLING (swelling...at injection site), VACCINATION SITE RASH (rash at injection site) and VACCINATION SITE PRURITUS (itchiness...at injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swelling...at injection site), VACCINATION SITE RASH (rash at injection site) and VACCINATION SITE PRURITUS (itchiness...at injection site). On 10-Mar-2021, the patient experienced VACCINATION SITE WARMTH (injection site...it doubled the size and swollen and hot). The patient was treated with HYDROCORTISONE ACETATE (CORTISONE [HYDROCORTISONE ACETATE]) (topical) for Allergy, at a dose of 1 dosage form. At the time of the report, VACCINATION SITE WARMTH (injection site..it doubled the size and swollen and hot), VACCINATION SITE SWELLING (swelling..at injection site), VACCINATION SITE RASH (rash at injection site) and VACCINATION SITE PRURITUS (itchiness..at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication was reported as hormone pills since an unknown start date. Treatment medications include allergy pill .
30 minutes after receiving vaccine patient felt like her throat was closing up. O2 sat 98%, no sob, no wheezing, lung sounds clear, HR 110. Benadryl 50mg IM given and taken to nurse treatment to monitor. Per Doctor no need to give epi pen, no difficulty swallowing or breathing, vitals stable, 106/69, HR 92, sat 100% on room air. Patient was monitored for 45 minutes after benadryl given and symptoms resolved. Patient went home in no distress.
sick; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   The reporter considered the sickness to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient's sibling. The age at vaccination was not reported. The reporter had the shingles twice and that was horrible and so he/she had not received the vaccine yet. The reporter was sort of worried about getting the vaccine because it made the patient really sick. The reporter guesses the vaccine would still be better than getting them (shingles) again. The follow-up would not possible as no contact details were available.
Friday , March 5 - Received shot at approx. 9:30am.  10:00 am feeling very tired. By 3:00pm feeling achy and feverish,  6pm full chills, headache, and fever and very achy.  At 7:00pm  took my temp. It was 100.4 degrees.  I took  3 -200mg Advil and went to bed.   Saturday, March 6 - woke at 6:30am feeling washed out.  By 8:00am was feeling a bit achy, took 3- 200mg Advil and by 10:00am was feeling much better.  Symptoms were completely gone by noon and have not recurred since.
I started to feel sick 11/23 and I thought it was sinus related then I felt like I was hit by a truck. I then left a voicemail during holiday, and they returned my call on 11/25. I took this two-pill prescription Paxlovid, and it worked very well. I am happy that it's over, but I have to wait some months to get the next shot.
Rednesss in injection site on 10/30. Went to ER on 11/1 /on antibiotics.
Localized irritation, itchiness, induration and redness on LU extremity. 24hrs. of administration.
Patient felt tired and lethargic the day of the shot, and went to bed early. He wok up the next day with a fever just under 102F. He had a splitting headache, body aches, and exhaustion. He spent the day sleeping, drinking water and eating soup. The following day (3rd day) he woke up with a lesser headache which dissipated throughout the day.
skin fell off; skin looks reddish, a light pink color; Fatigue; Dark spot on right hand below fingers area, like a large brown mole; Bad pain on left arm if had to lift it; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Dark spot on right hand below fingers area, like a large brown mole), PAIN IN EXTREMITY (Bad pain on left arm if had to lift it), SKIN EXFOLIATION (skin fell off), ERYTHEMA (skin looks reddish, a light pink color) and FATIGUE (Fatigue) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced RASH MACULAR (Dark spot on right hand below fingers area, like a large brown mole), PAIN IN EXTREMITY (Bad pain on left arm if had to lift it) and FATIGUE (Fatigue). On 25-Apr-2021, the patient experienced SKIN EXFOLIATION (skin fell off) and ERYTHEMA (skin looks reddish, a light pink color). On 11-Apr-2021, PAIN IN EXTREMITY (Bad pain on left arm if had to lift it) had resolved. On 12-Apr-2021, FATIGUE (Fatigue) had resolved. On 24-Apr-2021, RASH MACULAR (Dark spot on right hand below fingers area, like a large brown mole) had resolved. At the time of the report, SKIN EXFOLIATION (skin fell off) and ERYTHEMA (skin looks reddish, a light pink color) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported
Confusion, disorientation, c/o feeling hot/floshed hand tremer @ rest waeker grip on left arm  PERLA BP 170/100 168/98 BP and r WNL, no c/o SOB color good. States took regular meds this AM. Ambulance called- denies numbness  BP with paramedics 164/78; P 102
8 days after injection, area surrounding injection began to ache,  was swollen, red and hot to touch.
She had her arm a little sore for the first couple of days; a little bump size of a quarter appeared; Last night her arm started itching at the injection site; a red spot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (She had her arm a little sore for the first couple of days), VACCINATION SITE MASS (a little bump size of a quarter appeared), VACCINATION SITE PRURITUS (Last night her arm started itching at the injection site) and VACCINATION SITE ERYTHEMA (a red spot) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included DULOXETINE, CLONAZEPAM, GABAPENTIN and AMOXICILLIN for an unknown indication.    On 13-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Aug-2021, the patient experienced VACCINATION SITE MASS (a little bump size of a quarter appeared), VACCINATION SITE PRURITUS (Last night her arm started itching at the injection site) and VACCINATION SITE ERYTHEMA (a red spot). On an unknown date, the patient experienced PAIN IN EXTREMITY (She had her arm a little sore for the first couple of days). At the time of the report, PAIN IN EXTREMITY (She had her arm a little sore for the first couple of days) and VACCINATION SITE PRURITUS (Last night her arm started itching at the injection site) had resolved, VACCINATION SITE MASS (a little bump size of a quarter appeared) had not resolved and VACCINATION SITE ERYTHEMA (a red spot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medication also includes Inhaler.  It was stated that pharmacist recommended Benadryl cream which she could not use
Patient was having vomiting and abdominal pain within 24 hours post vaccines. Patient ended up having an appendectomy on 10.17.09. 11/2/2009 hospital records from 10/17-10/19/2009, Dc Dx acute Appendicitis  patient with c/o's nausea/vomiting, rlq abd pain and fever. PE noted tenderness rlq abd, Ct scan confirmed appendicitis. Tx: Lap Appy, Patient DC'd 10/19/2009   11/3/09:  Discharge Summary received for dates of service 10/17/09 to 10/19/09.  DX:  Acute Appendicitis. No new information.
mother called on 04/05/05 at 4:42 states just noticed rash mother instructed to bring pt to clinic pt seen by DR.
about 1 hr p/immun pt c/o numbness, tingling in both hands; no SOB, diaphoresis; encouraged pt to notify MD if sx cont or worsen; pt had some nausea & h/a;
BLOOD CLOT; BROKE TAIL BONE; VACCINE EXPOSURE DURING PREGNANCY; This spontaneous pregnancy report was received from a pharmacist via a company representative, and concerned an approximately 40 year old female. The patient's height, weight, and medical history were not reported.  The patient received Covid-19 vaccine Ad26.COV2.S (suspension for injection, route of administration not reported, batch number: unknown) dose and vaccination site were not reported, administered in 2021 for prophylactic vaccination. No concomitant medications were reported.  In 2021, the patient experienced vaccine exposure during pregnancy. The date of the patient's last menstrual period and expected delivery date were not provided. In 2021, the patient experienced broke tail bone during labor and gave birth (live birth).  On an unspecified date in 2021, the patient experienced a blood clot and died. It was noted that she was at high risk for clots because she was 4 weeks post partum (gravida 1, para 1).  Action taken with Covid-19 vaccine Ad26.COV2.S was not applicable. The patient died of a blood clot and broke tail bone in 2021; the outcome of vaccine exposure during pregnancy was not reported. It was unspecified if an autopsy was performed. This report was serious (Death). This case, from the same reporter is linked to 20210430297.; Sender's Comments: V0: The case concerns a pregnant female subject around age of 40, who developed thrombosis, skeletal injury and exposure during pregnancy an unspecified time after Janssen COVID-19 vaccine was administered intramuscularly for prevention of symptomatic SARS-CoV-2 virus infection. The subject's past medial history, last menstrual period, estimated date of delivery and concomitant medications were not provided. Per the reporter (pharmacist) the patient was at a high risk for blood clots because she was 4 weeks post-partum. The patient broke her tail bone during the labor, gave a birth, and later died of a blood clot. No additional information was provided. It is not known whether the autopsy was performed. Given alternative explanation and risk factors of pregnancy, labor and skeletal injury (trauma) the event of thrombosis is considered inconsistent with the causal association to immunization, per the WHO causality classification for adverse events following immunization. Events of skeletal injury was result of an accident and therefore not considered related. Company causality for event of thrombosis is considered not related to Janssen COVID-19 vaccine (Level 4 -Insufficient information available to confirm a possible, probable or a definitive case of venous thrombosis, per the Brighton Collaboration case definition); Reported Cause(s) of Death: BLOOD CLOTS; BROKE TAIL BONE
Patient reported to pharmacy on July 5th to report swelling and pain in right side of face and neck. She was on her way to emergency room or clinic seeking steroids to calm the reaction
Rec'd phone call on 2.2.12 at 10 am from pediatrician from Medical Center.  States pt brought to Medical Center at 11 pm on 2.1.12 with c/o temp of >104 and febrile seizures.  Dr. treated pt.  Pt had ID consult with another Dr.  Dr. notified our clinic physician.  Dr. stated she will refer pt for neuro consult.  Pt recovered and is doing well.
Patient received varicella vaccine and two days later developed Shingles. He had a history of chickenpox he believes.
After injection she stood up at sat down of stool in room she began to slump over. Father caught her and eased her to floor. Ammonia used pt lethargic RN and father of pt lifted her to exam table. Her eyes were bloodshot sclera red bilateral very shaky BP. 100/60 pulse regular. Lethargic but oriented to place and person. 911 called for transport to ER.
pt recv vax 19SEP97 & 1OCT97 devel rash that lasted for 6 days & a fever that lasted for 5 days;pt was seen by MD;pt recovered;
About 3 weeks after the booster vaccination (I had received JJ in April 2021, Moderna for booster in November 2021) I started to get weakness and numbing in my left leg. It continued to progress up my left leg and thigh, even with stretching and moving frequently. The weakness also started to occur in my right leg. Within 3 days of the onset of symptoms I didn't have enough strength to even walk up the stairs and the numbing progressed into tingles and involuntary shaking, like when you are super cold and get a few shakes, of my legs. I was admitted to the ER. Within 12 hours of my admittance, I was paralyzed from my torso down. I could not urinate or expel bowels. I could not move my legs or hardly sit up on my own. My skin had a burning feeling when it was touched, especially when something cold touched my skin. I was treated with IVIG for potential guillian barre. The strongest concerns for this illness, as it was traveling up my body, was how it could affect the muscles in my heart, lungs and throat that could put me on a ventilator if I could not continue to breath on my own due to paralysis. I stayed in the hospital for a full 7 days and was sent home at that point to continue healing at home with visits from nurses and physical therapy. After 4 months of recovery and testing, I still have weakness in my hips/legs and nerve pain that causes my skin to be very sensitive to touch and cold.
Right shoulder weakness 11 days after ADACEL injection patient had reported redness, bruising and pain at injection site radiating to neck x 1 only. Proximal muscle weakness sensory intact. Referral made to neurology.
Local reaction to DTP vaccine lt thigh has redness 10cm - no induration pt sensitive to touch
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 18-JUL-2017, the patient was vaccinated with an expired dose of GARDASIL intramuscularly, lot # M014929, expiry date 27-MAY-2017. No adverse effects were reported. Additional information is not expected.
Rash, bumps, appears to be mild chicken pox.  Worse throughout day.
Started  me treating the evening I got the vaccine.   A few days after menstration stopped, I started menstrating again.
Red patch on and surrounding injection area. Patch was warm for the first three days and was itchy. Redness and itchiness lasted for 18 days.  At  27 days after vaccine, redness has faded and itchiness is gone except immediately after showering when redness intensifies for about an hour.
A spontaneous report was received from a consumer concerning herself, who is a 76-years-old female patient received COVID-19 vaccine (mRNA-1273) and experienced events swollen(vaccination site swelling), sore/vaccination site pain, warm to touch/vaccination site warmth, red/vaccination site erythema, itchy/vaccination site pruritus. The patient's medical history was not provided. Concomitant medications reported were Sitagliptin Phosphate, Metformin, Furosemide, Warfarin, Olmesartan, Rosuvastatin for drug use for unknown indication. On 16 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 028LZ0A) Intramuscularly in the right arm for prophylaxis of COVID-19 infection. On 28 Jan 2021, patient experienced injection site is itchy and red as. When I first got the vaccine the site was swollen, sore, warm to touch, red. Action taken with mRNA-1273 in response to the events was not reported. The outcome of events swollen, sore, warm to touch, red, itchy was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Woke up with a sore-stiff underarm and swollen lymph node.  Advised to take tylenol and ice the area for the next few days.  Today is day 3, still a little sore and swollen but it is going down.
The pt experienced swelling, redness, warmth of shoulder and upper back and lower arm and fingers.
Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnancy) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 026L20A) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on 20-Aug-2020 and the estimated date of delivery was 27-May-2021. On 05-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  nineteenth week of the pregnancy.  On 05-Jan-2021, EXPOSURE DURING PREGNANCY (Pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Sep-2020, Pregnancy test: positive (Positive) Positive.
This case was reported by a consumer via call center representative and described the occurrence of fatigue in a adult female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (1st dose received on unknown date and the patient had no problems from the dose). On 25th March 2019, the patient received the 2nd dose of SHINGRIX. On 25th March 2019, 3 hrs after receiving SHINGRIX, the patient experienced fatigue, muscle pain, chills, fever and tremor. On 27th March 2019, the outcome of the fatigue, muscle pain, chills, fever and tremor were recovered/resolved. The reporter considered the fatigue, muscle pain, chills, fever and tremor to be related to SHINGRIX. Additional case details were provided as follows: The age at vaccination was not reported. The patient received the dose of SHINGRIX vaccine on Monday around midday. By 3 pm, the patient began to feel extremely fatigued and experienced muscle aches. These progressively got worse into the evening, when chills and fever started. The chills were so bad she was shaking. The patient had a fever over 100 for the entire next day. By Wednesday morning from the day of reporting, the patient was feeling better. The patient did not gave the consent for follow up. Lab Comments: On March 2019, the patient had fever over 100.
2 Bumps by my Collarbone after getting the 2nd Injection in my left arm; swollen lymph nodes after the 2nd Moderna Injecction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SKIN MASS (2 Bumps by my Collarbone after getting the 2nd Injection in my left arm) and LYMPHADENOPATHY (swollen lymph nodes after the 2nd Moderna Injecction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SKIN MASS (2 Bumps by my Collarbone after getting the 2nd Injection in my left arm) and LYMPHADENOPATHY (swollen lymph nodes after the 2nd Moderna Injecction). At the time of the report, SKIN MASS (2 Bumps by my Collarbone after getting the 2nd Injection in my left arm) and LYMPHADENOPATHY (swollen lymph nodes after the 2nd Moderna Injecction) outcome was unknown.            Concomitant medications were not provided by the reporter.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was Not applicable.   Reporter did not allow further contact